Stocktoria

MANNKIND CORP MNKD

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-07-28 · LEI

MANNKIND CORP financials (annual)

Revenue
$174.8M $11.7M $27.9M $63.0M $65.1M $75.4M $99.8M $199.0M $285.5M $349.0M 2016201720182019202020212022202320242025
Net income
$125.7M -$117.3M -$87.0M -$51.9M -$57.2M -$80.9M -$87.4M -$11.9M $27.6M $5.9M 2016201720182019202020212022202320242025
Free cash flow
-$79.2M -$38.1M -$91.0M -$28.9M -$73.2M -$88.3M -$8.3M $32.8M $13.7M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$349.0M$285.5M$199.0M$99.8M$75.4M$65.1M$63.0M$27.9M$11.7M$174.8M
SG&A expense$144.1M$94.3M$94.3M$91.5M$77.4M$59.0M$74.7M$79.7M$75.0M$46.9M
Operating income$38.8M$72.6M$8.7M-$64.1M-$47.0M-$47.9M-$44.6M-$76.6M-$108.2M$67.3M
Interest expense$15.2M$15.0M$15.2M
Income tax-$4.5M$2.9M$1.6M$0$0-$218,000$0$240,000$51,000$0
Net income$5.9M$27.6M-$11.9M-$87.4M-$80.9M-$57.2M-$51.9M-$87.0M-$117.3M$125.7M
EPS (diluted)$0.02$0.10$-0.04$-0.34$-0.32$-0.26$-0.60$-1.13$1.36
Operating cash flow$18.3M$42.5M$34.1M-$80.7M-$61.7M-$28.1M-$88.5M-$37.7M-$64.8M-$78.1M
Free cash flow$13.7M$32.8M-$8.3M-$88.3M-$73.2M-$28.9M-$91.0M-$38.1M-$79.2M
Cash & equivalents$74.9M$46.3M$238.5M$69.8M$124.2M$67.0M$29.9M$71.2M$43.9M$22.9M
Inventory$35.3M$27.9M$28.5M$21.8M$7.2M$5.0M$4.2M$3.6M$2.7M$2.3M
Total assets$792.2M$393.8M$475.2M$295.3M$321.2M$108.6M$93.7M$107.7M$84.6M$107.1M
Total liabilities$843.2M$472.7M$721.4M$545.8M$530.5M$289.0M$284.3M$282.8M$299.3M$290.7M
Shareholders' equity-$51.0M-$78.8M-$246.2M-$250.5M-$209.3M-$180.4M-$190.5M-$175.1M-$214.7M-$183.6M

Growth · year-over-year · Revenue CAGR 8%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+22.2%+43.5%+99.4%+32.2%+15.8%+3.3%+126.3%+137.2%-93.3%
Net income growth-78.7%-193.4%
EPS growth-80.0%-183.1%
Free cash flow growth-58.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.